Shares in US pharma giant Merck & Co (NYSE: MRK) were nearly 2% higher in early trading Monday.

US ophthalmic gene therapy company Beacon Therapeutics, which is focused on restoring the vision of patients with blinding ...

Shares of Avidity Biosciences (Nasdaq: RNA) were up almost 5% at $38.00 pre-market today, as it announced the accelerated ...

UK pharma major GSK has appointed Sanjay Gurunathan as senior vice president and global head vaccines and infectious disease ...

Knight will have the exclusive rights to distribute, promote, market and sell the products in Canada, and said it will begin ...

French pharma major Sanofi (Euronext: SAN) has started early global shipments of its monoclonal antibody Beyfortus ...

Swiss skincare specialist Galderma has announced two-year data from a new interim analysis of a long-term extension study ...

US biotech Regeneron Pharmaceuticals (Nasdaq: REGN) and French pharma major Sanofi (Euronext: SAN) on Saturday presented ...

South Korea’s biosimilar drug developer Samsung Bioepis has announced that the company has entered into a license, ...

Privately-held Italian pharma company Italfarmaco today revealed that the European Commission (EC) has granted conditional ...

As Denmark presses ahead with a major health reform, a coalition of rare disease advocates and clinicians is urging the ...

George Medicines, a late-stage UK-based biopharmaceutical company focused on addressing unmet needs in cardiometabolic ...